NantKwest and Viracta Therapeutics Announce Series B Financing and Immunotherapy Partnership
Apr 04, 2017 12:00 pm UTC| Business
CULVER CITY, Calif. and SAN DIEGO, April 04, 2017 -- NantKwest, Inc. (Nasdaq:NK) and Viracta Therapeutics, Inc. announced the initial closing of a Series B Preferred financing round of up to $18.4 million with...
Proofpoint to Report First Quarter 2017 Financial Results
Apr 04, 2017 12:00 pm UTC| Business
SUNNYVALE, Calif., April 04, 2017 -- Proofpoint, Inc. (NASDAQ:PFPT), a leading next-generation security and compliance company, today announced it will issue a press release reporting financial results for the first...
76% of Respondents See Ransomware as Significant Business Threat, Says Varonis ISMG Survey
Apr 04, 2017 12:00 pm UTC| Business
NEW YORK, April 04, 2017 -- Varonis Systems, Inc. (NASDAQ:VRNS), a leading provider of software solutions that protect data from insider threats and cyberattacks, today announced new research, undertaken by Information...
Apr 04, 2017 12:00 pm UTC| Business
MALVERN, Pa., April 04, 2017 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led, biotechnology company focused on defining new standards of care in medical and aesthetic dermatology, today announced that...
Apr 04, 2017 12:00 pm UTC| Business
WALTHAM, Mass., April 04, 2017 -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today the closing of the licensing agreement with Endoceutics, Inc. for the U.S. commercial rights to IntrarosaTM (prasterone)....
Empire State Bank to open two new branch locations in the New York City market
Apr 04, 2017 12:00 pm UTC| Business
NEWBURGH, N.Y., April 04, 2017 -- The Directors of Empire State Bank, the wholly owned subsidiary of ES Bancshares, Inc. (OTC:ESBS), are happy to announce that the Bank intends to open two branch locations, one in...
uniQure Publishes Data Demonstrating Wide Distribution of AAV5 in the Central Nervous System
Apr 04, 2017 11:42 am UTC| Business
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, April 04, 2017 -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced...